Free Trial

OptimizeRx (OPRX) Competitors

$12.89
-0.19 (-1.45%)
(As of 05/21/2024 ET)

OPRX vs. RMNI, ZFOX, DHX, STCN, EGIO, MCHX, EEX, RGP, ZH, and LQDT

Should you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Rimini Street (RMNI), ZeroFox (ZFOX), DHI Group (DHX), Steel Connect (STCN), Edgio (EGIO), Marchex (MCHX), Emerald (EEX), Resources Connection (RGP), Zhihu (ZH), and Liquidity Services (LQDT). These companies are all part of the "business services, not elsewhere classified" industry.

OptimizeRx vs.

Rimini Street (NASDAQ:RMNI) and OptimizeRx (NASDAQ:OPRX) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Rimini Street has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.

Rimini Street currently has a consensus target price of $4.50, suggesting a potential upside of 73.08%. OptimizeRx has a consensus target price of $16.00, suggesting a potential upside of 24.13%. Given OptimizeRx's higher possible upside, analysts clearly believe Rimini Street is more favorable than OptimizeRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rimini Street
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OptimizeRx
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

In the previous week, OptimizeRx had 10 more articles in the media than Rimini Street. MarketBeat recorded 13 mentions for OptimizeRx and 3 mentions for Rimini Street. OptimizeRx's average media sentiment score of 0.59 beat Rimini Street's score of 0.06 indicating that Rimini Street is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rimini Street
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OptimizeRx
1 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Rimini Street has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Rimini Street, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rimini Street$431.50M0.54$26.06M$0.2410.83
OptimizeRx$71.52M3.29-$17.57M-$1.02-12.64

Rimini Street received 9 more outperform votes than OptimizeRx when rated by MarketBeat users. Likewise, 63.49% of users gave Rimini Street an outperform vote while only 63.16% of users gave OptimizeRx an outperform vote.

CompanyUnderperformOutperform
Rimini StreetOutperform Votes
153
63.49%
Underperform Votes
88
36.51%
OptimizeRxOutperform Votes
144
63.16%
Underperform Votes
84
36.84%

Rimini Street has a net margin of 5.02% compared to Rimini Street's net margin of -23.10%. Rimini Street's return on equity of -6.96% beat OptimizeRx's return on equity.

Company Net Margins Return on Equity Return on Assets
Rimini Street5.02% -66.46% 8.75%
OptimizeRx -23.10%-6.96%-5.53%

73.8% of Rimini Street shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 41.3% of Rimini Street shares are owned by insiders. Comparatively, 4.4% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Rimini Street beats OptimizeRx on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPRX vs. The Competition

MetricOptimizeRxBusiness services IndustryComputer SectorNASDAQ Exchange
Market Cap$235.50M$19.05B$20.70B$8.00B
Dividend YieldN/A3.42%2.72%3.91%
P/E Ratio-12.6439.79251.3818.66
Price / Sales3.293.27547.1384.55
Price / CashN/A23.0229.5729.27
Price / Book1.855.276.974.46
Net Income-$17.57M$536.61M$605.68M$213.38M
7 Day Performance-2.13%-0.10%0.29%0.46%
1 Month Performance41.80%2.98%6.09%5.46%
1 Year Performance6.00%10.17%26.24%8.74%

OptimizeRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMNI
Rimini Street
3.117 of 5 stars
$2.37
+2.2%
$4.50
+89.9%
-35.6%$214.27M$432.73M9.882,120News Coverage
ZFOX
ZeroFox
1.2469 of 5 stars
$1.14
flat
$3.50
+207.0%
+38.8%$142.32M$233.30M-0.40914
DHX
DHI Group
4.0716 of 5 stars
$2.47
+0.8%
$7.00
+184.0%
-33.5%$118.39M$151.88M61.64460
STCN
Steel Connect
0 of 5 stars
$12.55
+0.7%
N/A+55,908.0%$78.89M$171.33M12.631,000
EGIO
Edgio
0.9898 of 5 stars
$10.13
+7.7%
$33.33
+229.1%
-51.0%$59.06M$338.60M-0.40822News Coverage
MCHX
Marchex
2.0114 of 5 stars
$1.34
+5.5%
N/A-31.3%$58.50M$49.91M-8.93164Analyst Forecast
EEX
Emerald
1.945 of 5 stars
$5.90
-0.3%
$8.20
+39.0%
+78.6%$372.01M$393.90M-7.87673
RGP
Resources Connection
2.5586 of 5 stars
$11.56
-0.4%
$13.50
+16.8%
-28.2%$390.84M$775.64M17.524,062News Coverage
ZH
Zhihu
0 of 5 stars
$3.92
+7.7%
N/A-30.5%$402.15M$591.40M-3.442,731Upcoming Earnings
Gap Up
High Trading Volume
LQDT
Liquidity Services
3.2283 of 5 stars
$19.23
+1.2%
$27.00
+40.4%
+24.9%$586.13M$314.46M29.59716

Related Companies and Tools

This page (NASDAQ:OPRX) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners